Analyst Ratings for Belite Bio, Inc, ADR (BLTE)
BLTE Rating Summary
BLTE Price Target Summary
- Highest: $60.00 (Maxim Group)
- Lowest: $25.00 (Leerink Partners)
- Average: $46.75
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$46.75 (+35.1%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$46.75 (+35.1%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/14/2023 | Maxim Group | Jason McCarthy | New Coverage | Buy (N/A) |
60.00 (N/A) |
44.20 (34.60) |
-21.72% | Details |
| 7/28/2023 | Cantor Fitzgerald | Jennifer Kim | New Coverage | Overweight (N/A) |
43.00 (N/A) |
20.55 (34.60) |
68.37% | Details |
 |
||||||||
|
||||||||
|
||||||||
